News | Lund universityExcellence of diabetes research in Swedenhttps://ludc.prodwebb.lu.se/
Prize awarded to research in zebrafish that could lead to new treatments for diabetes https://ludc.prodwebb.lu.se/article/prize-awarded-to-research-in-zebrafish-that-could-lead-to-new-treatments-for-diabetes
In his research in zebrafish, Olov Andersson of Karolinska Institutet strives to generate insulin-producing cells and new treatment methods for diabetes. This has led to his selection as a recipient of the Leif C. Groop award for outstanding research, awarded by the Lund University Diabetes Centre and sponsored by Novo Nordisk Sweden.1143Tue, 05 Mar 2019 09:13:51 +0100News | Lund universityBig data, muffins and space travelhttps://ludc.prodwebb.lu.se/article/big-data-muffins-and-space-travel
What do muffins and space travel have in common?
Answer: They affect our genes through altered DNA methylation patterns.
Two researchers who studied this recently met at the public defence of a doctoral thesis at Lund University.1066Tue, 29 Jan 2019 14:10:38 +0100News | Lund universityRegister Now: FASEB Science Research Conference (SRC) – The Smooth Muscle Conference https://ludc.prodwebb.lu.se/article/register-now-faseb-science-research-conference-src-the-smooth-muscle-conference
Registration is now open for The Smooth Muscle Conference, taking place July 14-19, 2019, in West Palm Beach, Florida. Organized by Chairs Jonathan Jaggar, PhD, University of Tennessee; and Maria Gomez, PhD, Lund University, with support from the Federation of American Societies for Experimental Biology (FASEB), this conference is highly interactive and brings together an interdisciplinary group of scientists from academic and clinical backgrounds who study and conduct research on smooth muscle.1061Mon, 21 Jan 2019 11:19:29 +0100News | Lund universityMetabolic research today and beyondhttps://ludc.prodwebb.lu.se/article/metabolic-research-today-and-beyond
How far has precision medicine come? What challenges are we facing within clinical and translational research?
See the seminar on metabolic research in retrospect. (Most of the lectures are held in Swedish)1056Tue, 15 Jan 2019 15:26:07 +0100News | Lund universitye-Health - what is needed for research to reach clinical benefit?https://ludc.prodwebb.lu.se/article/e-health-what-is-needed-for-research-to-reach-clinical-benefit
On November 30th a well-attended seminar rocusing on issues needed to consider already at an early stage when developing e-Health solutions was organized by LUDC Innovation Office, the Department of Clinical Sciences Malmö, and Medeon Science Park.1054Thu, 20 Dec 2018 12:52:32 +0100News | Lund universityNew findings on intestinal flora development in infants https://ludc.prodwebb.lu.se/article/new-findings-on-intestinal-flora-development-in-infants
In the so far largest clinical study of the development of microbiomes, i.e. intestinal flora, in infants, researchers at the Baylor College of Medicine, USA, have found that development takes place in different phases that can be associated with lifestyle changes during the early stages in life. The findings are based on samples from the TEDDY study and are published in two articles in the scientific journal Nature.1046Fri, 26 Oct 2018 11:38:55 +0200News | Lund universityNew discovery restores insulin cell function in type 2 diabeteshttps://ludc.prodwebb.lu.se/article/new-discovery-restores-insulin-cell-function-in-type-2-diabetes
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown that it is possible to prevent the development of the disease. The findings are published in the scientific journal Cell Metabolism.1036Mon, 08 Oct 2018 15:32:36 +0200News | Lund universityNew study of babies in Skåne to prevent type 1 diabetes https://ludc.prodwebb.lu.se/article/new-study-of-babies-in-skane-to-prevent-type-1-diabetes
Can insulin absorbed in small doses through food in early childhood get the immune system accustomed to insulin and thereby delay – or prevent – type 1 diabetes?
Researchers hope to find the answer through POInT, a study starting in Skåne this autumn.1033Mon, 08 Oct 2018 08:57:56 +0200News | Lund universityNew function of a key component in the immune system discovered https://ludc.prodwebb.lu.se/article/new-function-of-a-key-component-in-the-immune-system-discovered
The complement proteins that circulate in our blood are an important part of our immune system. They help identify bacteria, viruses and other harmful organisms, making it easier for our white blood cells to find and neutralise dangerous microbes. Researchers at Lund University in Sweden have now discovered a previously unknown function of the central complement protein, C3, which describes how C3 regulates autophagy. 1027Fri, 05 Oct 2018 11:41:55 +0200News | Lund universityInternational diabetes study receives SEK 40 million to continuehttps://ludc.prodwebb.lu.se/article/international-diabetes-study-receives-sek-40-million-to-continue
The TEDDY Study has increased our knowledge about what happens prior to the onset of autoimmune diabetes (type 1 diabetes) and has shown that a stomach infection can trigger coeliac disease. Lund University in Sweden has now received just over SEK 40 million from the American National Institutes of Health (NIH) to continue the TEDDY Study for another five years.1028Wed, 03 Oct 2018 12:01:28 +0200News | Lund universityThe father of diabetesportalen.se retireshttps://ludc.prodwebb.lu.se/article/the-father-of-diabetesportalense-retires
Tord Ajanki started diabetesportalen.se just over a decade ago. Now he is to relinquish the editorship and retire.
“It feels strange, good in one way, but it’s difficult to stop doing something that you have been involved in for so long”, he says.
1026Tue, 02 Oct 2018 12:48:22 +0200News | Lund universityMapping the mechanisms behind type 2 diabeteshttps://ludc.prodwebb.lu.se/article/mapping-the-mechanisms-behind-type-2-diabetes
The islets of Langerhans in the pancreas contain not only insulin-producing cells, but also four other hormone-producing cell types. Using a new method, researchers are to study their interaction by mapping previously unknown genetic networks.
“It will give us new possibilities to direct medicines at new targets”, says associate professor Nils Wierup who will present the first part of the study at EASD in October.
1024Tue, 02 Oct 2018 12:37:52 +0200News | Lund universityLeif C. Groop award: Time for nominationhttps://ludc.prodwebb.lu.se/article/leif-c-groop-award-time-for-nomination
Who will be the winner of the Leif C. Groop award for outstanding diabetes research 2018?
Deadline for nominations October 31.1021Mon, 01 Oct 2018 14:51:33 +0200News | Lund universityEXODIAB/LUDC-IRC: A powerhouse for diabetes researchhttps://ludc.prodwebb.lu.se/article/exodiabludc-irc-a-powerhouse-for-diabetes-research
What are the challenges within diabetes research today? And what are the strenghts of Lund university Diabetes Centre (LUDC) to meet those challenges?
1017Fri, 28 Sep 2018 15:38:58 +0200News | Lund universityEarly prediction of autoimmune (typ1 1) diabeteshttps://ludc.prodwebb.lu.se/article/early-prediction-of-autoimmune-typ1-1-diabetes
Review in Diabetologia (2017).
Authors: Simon E Regnell and Åke Lernmark.1013Thu, 23 Aug 2018 13:56:40 +0200News | Lund universityScreening for autoimmune type 1 diabeteshttps://ludc.prodwebb.lu.se/article/screening-for-autoimmune-type-1-diabetes
Seminar during the politician week in Visby, Sweden, about screening for autoimmune type 1 diabetes.
See the presentations and panel discussion in Swedish again afterwards.1012Mon, 20 Aug 2018 09:59:42 +0200News | Lund universityWhat is your food pattern?https://ludc.prodwebb.lu.se/article/what-is-your-food-pattern
Do you eat a lot of chicken, pasta, cheese, dressing and oils? Or are you one of those who consume a lot of yogurt with cereal, but stay away from coffee and meat? Researchers at Lund University in Sweden have studied different food patterns and found that some consumption patterns are healthier than others.1010Fri, 06 Jul 2018 20:15:17 +0200News | Lund universityParadigm shift in the diagnosis of diabeteshttps://ludc.prodwebb.lu.se/article/paradigm-shift-in-the-diagnosis-of-diabetes
A completely new classification of diabetes which also predicts the risk of serious complications and provides treatment suggestions. We are now seeing the first results of ANDIS – a study covering all newly diagnosed diabetics in southern Sweden — published in The Lancet Diabetes &amp; Endocrinology.961Fri, 02 Mar 2018 08:38:51 +0100News | Lund university“Death receptors” – new markers for type 2 diabetes and cardiovascular diseasehttps://ludc.prodwebb.lu.se/article/death-receptors-new-markers-for-type-2-diabetes-and-cardiovascular-disease
Researchers at Lund University in Sweden have found that the presence of death receptors in the blood can be used to directly measure the risk of developing cardiovascular diseases and type 2 diabetes. “We see that people with known risk factors such as high blood sugar and high blood fats also have heightened death receptor levels”, says Professor Jan Nilsson who led the study.947Thu, 14 Dec 2017 14:37:12 +0100News | Lund universityNordic conference in Malmö about Precision Medicine in the futurehttps://ludc.prodwebb.lu.se/article/nordic-conference-in-malmo-about-precision-medicine-in-the-future
December 4-5, nordic researchers gathered in Malmö to discuss future challenges in precision medicine, a research field where diagnosis and treatment are based on the individual´s genetic and biological conditions. Focus is on our common and increasing diseases diabetes, cardiovascular disease, cancer and psychiatric diagnosis. 948Thu, 14 Dec 2017 14:33:22 +0100News | Lund universityThe risk of type 1 diabetes not increased by swine flu vaccine Pandemrixhttps://ludc.prodwebb.lu.se/article/the-risk-of-type-1-diabetes-not-increased-by-swine-flu-vaccine-pandemrix
There has been a fear that the swine flu vaccine, Pandemrix, would increase the risk of autoimmune diseases other than narcolepsy. However, a new study of children from Sweden and Finland shows that the vaccine increased neither the risk of developing autoantibodies against insulin-producing beta cells nor the occurrence of type 1 diabetes.909Fri, 17 Nov 2017 08:47:03 +0100News | Lund universityNew drink keeps blood sugar in checkhttps://ludc.prodwebb.lu.se/article/new-drink-keeps-blood-sugar-in-check
Food researchers at Lund University in Sweden have discovered that consuming small amounts of chromium mixed with certain amino acids before eating is healthy. Why? Well, this mixture diluted in water suppresses the blood sugar spike that occurs when we eat. Now, they are hoping that the drink – which tastes like ordinary mineral water – will be able to compete with soft drinks and flavoured waters.908Fri, 17 Nov 2017 08:43:25 +0100News | Lund universityNewborn babies to be screened for studies on type 1 diabetes and celiac disease (gluten intolerance)https://ludc.prodwebb.lu.se/article/newborn-babies-to-be-screened-for-studies-on-type-1-diabetes-and-celiac-disease-gluten-intolerance
Can insulin taken as an infant in small doses together with food render the immune system used to insulin and thus prevent type 1 diabetes? Can a gluten-free diet and probiotics prevent celiac disease (so called gluten intolerance)? These questions will be asked by two separate studies that are being planned at Lund University in Sweden. A new comprehensive screening of newborn babies in southern Sweden is projected to commence this spring, in order to identify children with an elevated risk of type 1 diabetes or celiac disease.906Fri, 17 Nov 2017 08:36:58 +0100News | Lund universityLUDC-IRC ready for take offhttps://ludc.prodwebb.lu.se/article/ludc-irc-ready-for-take-off
Taking advantage of a novel sub-classification of diabetes LUDC-IRC, a newly launched collaboration between academia, the health care system and industry, aims at delivering precision medicine in diabetes.894Thu, 14 Sep 2017 14:56:25 +0200News | Lund universityNew research describes the differences between mice and humanshttps://ludc.prodwebb.lu.se/article/new-research-describes-the-differences-between-mice-and-humans
Research from King’s College in London, UK, and Lund University in Sweden could explain why diabetes drugs which have worked in animal experiments are not equally successful in humans. The researchers discovered differences – but also unknown similarities – in the function of insulin-producing beta cells.888Mon, 03 Jul 2017 11:14:55 +0200News | Lund universityThe role of vitamin A in diabeteshttps://ludc.prodwebb.lu.se/article/the-role-of-vitamin-a-in-diabetes
There has been no known link between diabetes and vitamin A -- until now. A new study suggests that the vitamin improves the insulin producing β-cell´s function.The researchers initially discovered that insulin-producing beta-cells contain a large quantity of a cell surface receptor for vitamin A.866Thu, 15 Jun 2017 10:33:58 +0200News | Lund university200.000 euro to diabetes researchhttps://ludc.prodwebb.lu.se/article/200000-euro-to-diabetes-research
Four researchers have been awarded grants from The Bo and Kerstin Hjelt Diabetes Foundation. The grant consists of Euro 50 000 each and are aiming towards better treatments and prevention of type 2-diabetes.857Mon, 29 May 2017 10:55:51 +0200News | Lund universityFrom injections to pills - the research on neonatal diabeteshttps://ludc.prodwebb.lu.se/article/from-injections-to-pills-the-research-on-neonatal-diabetes
They govern everything we think and do, they give us the ability to feel pain and to secrete insulin: they are the ion channels that are present in every one of our cells and that control the electrical impulses in our nerve and muscle cells.
“For me, they are the very spark of life”, says Dame Frances Ashcroft, professor at the University of Oxford, who is also now to be an honorary doctor at Lund University.
855Wed, 24 May 2017 15:34:03 +0200News | Lund universitySuccessful research funded by the European Research Councilhttps://ludc.prodwebb.lu.se/article/successful-research-funded-by-the-european-research-council
Six researchers from Lund University Diabetes Centre have recieved prestigous grants from the European Research Council (ERC). In order to celebrate the success we invited the public to an open seminar. Some of the talks can be reviewed here (in Swedish).835Fri, 21 Apr 2017 09:54:40 +0200News | Lund universityUnique mapping of methylome in insulin-producing isletshttps://ludc.prodwebb.lu.se/article/unique-mapping-of-methylome-in-insulin-producing-islets
Throughout our lives, our genes are affected by the way we live. Diet, exercise, age and diseases create imprints that are stored in something called methylome. Now, for the first time, researchers at the Lund University Diabetes Centre in Sweden have been able to map the entire methylome in the pancreatic islets which produce insulin, and the researchers have made several important discoveries.813Fri, 24 Feb 2017 11:11:53 +0100News | Lund university100 million SEK for personalized medicine in Diabeteshttps://ludc.prodwebb.lu.se/article/100-million-sek-for-personalized-medicine-in-diabetes
Almost 0.5 billion people have diabetes globally, many of whom are unaware of their condition; within the next two decades, this number is expected to double, largely owing to a growing, ageing, and increasingly industrialized global population. Lund University receives 100 million SEK from The Swedish Foundation of Strategic Research to help stop this development.811Fri, 24 Feb 2017 11:09:05 +0100News | Lund universityAn Innovative Medicines Initiative Project for Precision Medicine in DKDhttps://ludc.prodwebb.lu.se/article/an-innovative-medicines-initiative-project-for-precision-medicine-in-dkd
BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-¬¬year project (total budget 28.9 Million Euro) with the aim to improve prevention and management of Diabetes Kidney Disease (DKD). Presently, there are no means to effectively prevent or cure DKD, which has reached epidemic dimensions and is the leading cause of end-stage renal disease. DKD patients are a very sick population with mortalities exceeding most cancers and who are underserved by inefficient and unsuccessful drug development. DKD remains a large unmet medical need. 809Fri, 24 Feb 2017 09:13:28 +0100News | Lund universityObesity reprogrammes muscle stem cellshttps://ludc.prodwebb.lu.se/article/obesity-reprogrammes-muscle-stem-cells
Obesity is associated with reduced muscle mass and impaired metabolism. Epigenetic changes that affect the formation of new muscle cells may be a contributing factor, according to new research from Lund University, Sweden.797Thu, 23 Feb 2017 13:08:59 +0100News | Lund universityBeat-DKD An Innovative Medicines Initiative Project for Precision Medicine in DKDhttps://ludc.prodwebb.lu.se/article/beat-dkd-an-innovative-medicines-initiative-project-for-precision-medicine-in-dkd
BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-year project (total budget 28.9 Million Euro) with the aim to improve prevention and management of Diabetes Kidney Disease (DKD). Presently, there are no means to effectively prevent or cure DKD, which has reached epidemic dimensions and is the leading cause of end-stage renal disease. DKD patients are a very sick population with mortalities exceeding most cancers and who are underserved by inefficient and unsuccessful drug development. DKD remains a large unmet medical need. 1140Mon, 06 Feb 2017 00:00:00 +0100News | Lund universityInvestments in epigenetics to combat diabeteshttps://ludc.prodwebb.lu.se/article/investments-in-epigenetics-to-combat-diabetes
Charlotte Ling, professor of epigenetics at the Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden, has been awarded the European Research Council’s Consolidator Grant. The funding of EUR 2 million over five years will be used to develop new methods to improve prediction, prevention and treatment of type 2 diabetes.1139Wed, 14 Dec 2016 00:00:00 +0100News | Lund universityDecreased cell death and increased insulin production in pancreatic beta cells with genome edit by CRISPR/Cas9https://ludc.prodwebb.lu.se/article/decreased-cell-death-and-increased-insulin-production-in-pancreatic-beta-cells-with-genome-edit-by-crisprcas9
Using the CRISPR/Cas9 “gene scissors” researchers at Lund University Diabetes Centre in Sweden have managed to “turn off” an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells.1138Thu, 01 Dec 2016 00:00:00 +0100News | Lund universityType 2 diabetes and obesity - what do we really know?https://ludc.prodwebb.lu.se/article/type-2-diabetes-and-obesity-what-do-we-really-know
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics and lifestyle factors.315Tue, 18 Oct 2016 11:54:18 +0200News | Lund universityNew findings can lead to a new principle for treating diabetic kidney damagehttps://ludc.prodwebb.lu.se/article/new-findings-can-lead-to-a-new-principle-for-treating-diabetic-kidney-damage
One in three people with diabetes will face some form of renal impairment in the course of their lives. Studies conducted by researchers at the Lund University Diabetes Centre may lead to the development of an entirely new principle for treating type 2 diabetes and preventing kidney damage in the future.258Wed, 12 Oct 2016 11:50:28 +0200News | Lund universityReview: Type 2 diabetes and obesity – what do we really know?https://ludc.prodwebb.lu.se/article/review-type-2-diabetes-and-obesity-what-do-we-really-know
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics and lifestyle factors.244Wed, 12 Oct 2016 10:18:23 +0200News | Lund universityNo link between "obesity gene" and intentional weight losshttps://ludc.prodwebb.lu.se/article/no-link-between-obesity-gene-and-intentional-weight-loss
People with a hereditary risk of obesity lose as much weight as a result of better diet, exercise and weight loss drugs as the rest of the population, according to an international study presented in The BMJ.
“This indicates that even in people at genetic risk of obesity, lifestyle change is an effective way to lose weight”, says Professor Paul Franks of Lund University in Sweden, one of the researchers responsible for the study.223Thu, 22 Sep 2016 11:56:48 +0200News | Lund university Time to burie LADA? Interview with Leif Groop https://ludc.prodwebb.lu.se/article/time-to-burie-lada-interview-with-leif-groop
The dream of finding the “diabetes gene” is dead. However, partly thanks to Leif Groop – professor and multiple award recipient for his ground-breaking research – we will look at type 2 diabetes in a whole new way in the future. He is now retiring, and in an interview with diabetesportalen.se he looks back on his eventful career in research.224Mon, 04 Jul 2016 12:01:55 +0200News | Lund universityAntidiabetic effects discovered in the appetite hormone CART https://ludc.prodwebb.lu.se/article/antidiabetic-effects-discovered-in-the-appetite-hormone-cart
Researchers at Lund University in Sweden have discovered that the appetite hormone CART is regulated by glucose and is found in greater quantity in people with type 2 diabetes.
“This could be the body’s own defence mechanism to lower blood sugar levels in case of type 2 diabetes”, says Associate Professor Nils Wierup, in charge of the study.225Thu, 30 Jun 2016 15:33:02 +0200News | Lund universityLund initiates genetic sequencing study in diabetes families to provide new insights into what causes the diseasehttps://ludc.prodwebb.lu.se/article/lund-initiates-genetic-sequencing-study-in-diabetes-families-to-provide-new-insights-into-what-causes-the-disease
Lund University Diabetes Centre has entered into a collaboration with the Regeneron Genetics Center LLC (RGC) and the University of Helsinki involving exome-sequencing and whole genome array genotyping of greater than 9,000 individuals. The collaboration will involve the largest sequencing study in diabetes families to date and aims to help generate knowledge about how to predict diabetes, causes of disease and drug discovery targets.252Thu, 23 Jun 2016 11:12:16 +0200News | Lund universityTHADA - new findings in the role of the mother in type 2 diabeteshttps://ludc.prodwebb.lu.se/article/thada-new-findings-in-the-role-of-the-mother-in-type-2-diabetes
Research from Lund University in Sweden can explain why type 2 diabetes is inherited to a greater extent from an individual’s mother. The heredity of a previously known risk gene, THADA, has proven to be dominant if it comes from the mother, whereas it has little or no effect on the child’s risk of disease if it originates from the father. “Our research contributes to increased knowledge about the role of the mother and father in the heredity of type 2 diabetes”, says Rashmi Prasad.253Wed, 18 May 2016 11:27:32 +0200News | Lund universityNew findings explain the connection between melatonin and type 2 diabeteshttps://ludc.prodwebb.lu.se/article/new-findings-explain-the-connection-between-melatonin-and-type-2-diabetes
A new experimental and clinical study from Lund University in Sweden shows that the sleep hormone melatonin impairs insulin secretion in people with a common gene variant. “This could explain why the risk of type 2 diabetes is greater among, for instance, overnight workers or people with sleeping disorders”, says Professor Hindrik Mulder who is responsible for the study.256Fri, 13 May 2016 11:33:14 +0200News | Lund universityNew findings can lead to a new principle for treating diabetic kidney damagehttps://ludc.prodwebb.lu.se/article/new-findings-can-lead-to-a-new-principle-for-treating-diabetic-kidney-damage-0
One in three people with diabetes will face some form of renal impairment in the course of their lives. Studies conducted by researchers at the Lund University Diabetes Centre may lead to the development of an entirely new principle for treating type 2 diabetes and preventing kidney damage in the future.259Mon, 18 Apr 2016 11:50:28 +0200News | Lund universityNew method measures the risk of type 2 diabetes in bloodhttps://ludc.prodwebb.lu.se/article/new-method-measures-the-risk-of-type-2-diabetes-in-blood
Researchers at Lund University in Sweden have found a new type of biomarker that can predict the risk of type 2 diabetes, by detecting epigenetic changes in specific genes through a simple blood test.
“This could motivate a person at risk to change their lifestyle”, says Karl Bacos, researcher in epigenetics at Lund University.
The results are published today in Nature Communications.1137Thu, 31 Mar 2016 00:00:00 +0200News | Lund universityFocus on personalized treatment of type 2 diabetes and cardiovascular diseasehttps://ludc.prodwebb.lu.se/article/focus-on-personalized-treatment-of-type-2-diabetes-and-cardiovascular-disease
The European Research Council makes a large investment in diabetes research. A project led by Professor Paul Franks at Lund University Diabetes Centre is to develop methods that can be used in the design of preventive treatment for type 2 diabetes and cardiovascular disease.260Wed, 20 Jan 2016 11:53:48 +0100News | Lund universityWorld Diabetes Day in Malmö 2015https://ludc.prodwebb.lu.se/article/world-diabetes-day-in-malmo-2015
World Diabetes Day in Malmö was all about science. Researchers told the latest on diabetes research from stem cells to diet and the smallest hade the opportunity to becoming scientists - and learn what makes a strawberry a strawberry .196Fri, 20 Nov 2015 13:02:05 +0100News | Lund universityExercise is good for everyone - but some struggle more than othershttps://ludc.prodwebb.lu.se/article/exercise-is-good-for-everyone-but-some-struggle-more-than-others
People with increased risk of type 2 diabetes need to exercise more than others to achieve the same results, according to new research from Lund University in Sweden. 17Thu, 01 Oct 2015 00:00:00 +0200News | Lund university A yin-yang balancing act on blood vesselshttps://ludc.prodwebb.lu.se/article/a-yin-yang-balancing-act-on-blood-vessels
The incretin hormones GLP-1 and GIP act like the yin and yang on the body´s blood vessels. While GLP-1 has been associated with protective effects according to new research GIP can contribute to an increased risk of stroke. The findings are published in the scientific journal Diabetes.10Wed, 23 Sep 2015 00:00:00 +0200News | Lund universityNordic award for research into what is wrong with beta cells in type 2 diabeteshttps://ludc.prodwebb.lu.se/article/nordic-award-for-research-into-what-is-wrong-with-beta-cells-in-type-2-diabetes
In type 2 diabetes, the body’s cells are unable to assimilate the essential hormone insulin which is produced in the beta cells of the pancreas. Exactly what is wrong with the beta cells in type 2 diabetes is the question to which Professor Erik Renström at Lund University Diabetes Centre is searching for an answer. After just over twenty years of successful research in the field, he is now being awarded the Nordic area’s most important diabetes research prize for his work.14Mon, 27 Apr 2015 00:00:00 +0200News | Lund universityEarly signs in young children predict type 1 diabeteshttps://ludc.prodwebb.lu.se/article/early-signs-in-young-children-predict-type-1-diabetes
New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the bodys own insulin cells.13Fri, 06 Mar 2015 00:00:00 +0100News | Lund universityDiabetes drug could protect against low blood sugar https://ludc.prodwebb.lu.se/article/diabetes-drug-could-protect-against-low-blood-sugar
DPP-4 inhibitors are a group of drugs used to treat type 1 diabetes that lower high blood usgar levels by stimulating insulin production in the body. Researchers at Lund University in Sweden have now discovered that DPP-4 inhibitors are also effective against low blood sugar levels. The study, which was carried out on mice, has been published in the journal Diabetologia.11Fri, 20 Feb 2015 00:00:00 +0100News | Lund universityLagerstedt and Stenkula receive Novo Seed Granthttps://ludc.prodwebb.lu.se/article/lagerstedt-and-stenkula-receive-novo-seed-grant
Antidiabetics that also provide cardiovascular benefit is a key unmet need in diabetes treatment. ApoA-l is a protein shown to have both glucose lowering and cholesterol-lowering effects and has been investigated by Jens Lagerstedt and Karin Stenkula for its therapeutic potential. They have now received 2,5 million Danish kroner from the Novo Seeds for taking innvoation a step further. The goal is new drugs for patients with cardiovascular disease and diabetes.1136Wed, 21 Jan 2015 00:00:00 +0100News | Lund universityStudy of identical twins reveal type 2 diabetes clueshttps://ludc.prodwebb.lu.se/article/study-of-identical-twins-reveal-type-2-diabetes-clues
By studying identical twins, researchers from Lund University in Sweden have identified mechanisms that could be behind the development of type 2 diabetes. This may explain cases where one identical twin develops type 2 diabetes.1135Mon, 06 Oct 2014 00:00:00 +0200News | Lund university100 millions to strengthen the Swedish life science sectorhttps://ludc.prodwebb.lu.se/article/100-millions-to-strengthen-the-swedish-life-science-sector
The Swedish Innovation Agency, VINNOVA, has granted 100 MSEK to the Strategic Innovation Programme, SIO Chronic Diseases, with the overall aim to create better health and increased growth in Sweden.1134Tue, 10 Jun 2014 00:00:00 +0200News | Lund universityCystic fibrosis and diabetes link explainedhttps://ludc.prodwebb.lu.se/article/cystic-fibrosis-and-diabetes-link-explained
“The increased risk of diabetes has previously been explained by the fact that cystic fibrosis causes damage to the pancreas, where the blood-sugar regulating hormone insulin is produced. We are the first research group to show that the mutated gene that causes cystic fibrosis also plays an important role in the release of insulin. The risk of diabetes is not only explained by the destruction of the pancreas”, said Anna Edlund, a doctoral student at Lund University Diabetes Centre. 1133Mon, 02 Jun 2014 00:00:00 +0200News | Lund universityNanoparticles cause cancer cells to commit suicidehttps://ludc.prodwebb.lu.se/article/nanoparticles-cause-cancer-cells-to-commit-suicide
Using magnetically controlled nanoparticles to force tumour cells to ‘commit suicide’ sounds like science fiction, but could be a future part of cancer treatment.
“The clever thing about the technique is that we can target selected cells without harming surrounding tissue”, said Professor Erik Renström from Lund University.1132Thu, 03 Apr 2014 00:00:00 +0200News | Lund universityEpigenetic changes could explain type 2 diabeteshttps://ludc.prodwebb.lu.se/article/epigenetic-changes-could-explain-type-2-diabetes
People with type 2 diabetes have epigenetic changes on their DNA that healthy individuals do not have. This has been shown in a major study by researchers at Lund University. The researchers also found epigenetic changes of a large number of genes that contribute to reduced insulin production.
“This shows that the risk of developing type 2 diabetes is not only genetic, but also epigenetic”, said Charlotte Ling, who led the study.1131Fri, 07 Mar 2014 00:00:00 +0100News | Lund universityNew findings on gastric bypass and diabeteshttps://ludc.prodwebb.lu.se/article/new-findings-on-gastric-bypass-and-diabetes
The majority of gastic bypass patients mysterioulsy recover from their type 2 diabetes within days, before any weight loss has taken place. A study at Lund University Diabetes Centre in Sweden has now shown that the insulin-producing beta cells increase in number and performance after the surgery.1129Fri, 31 Jan 2014 00:00:00 +0100News | Lund universityGrants Hjelt foundationhttps://ludc.prodwebb.lu.se/article/grants-hjelt-foundation
Five researchers from Lund University and the University of Geneva has bedn granted altogether 200 000 Euro from Bo &amp; Kerstin Hjelt Foundation for type 2 diabetes.1130Fri, 31 Jan 2014 00:00:00 +0100News | Lund universityDiabetes link with dementia to be examinedhttps://ludc.prodwebb.lu.se/article/diabetes-link-with-dementia-to-be-examined
It is well known that type 2 diabetes raises the risk of dementia. The reasons for this are less clear, but one explanation could be insulin resistance in the brain, according to Malin Wennström, a researcher at Lund University´s Molecular Memory Research Unit.1128Mon, 13 Jan 2014 00:00:00 +0100News | Lund universityAwards for Leif Groophttps://ludc.prodwebb.lu.se/article/awards-for-leif-groop
Professor Leif Groop, international known diabetes researcher and coordinator of Lund University Diabetes Centre, is now assigned an other established award: Matti Äyräpää-award of 20 000 eur. The prize is awarded by the Finnish medical society Duodecim.
1127Thu, 09 Jan 2014 00:00:00 +0100News | Lund universityProfessor Leif Groop, Lund University has been awarded Söderbergska priset i medicin 2014https://ludc.prodwebb.lu.se/article/professor-leif-groop-lund-university-has-been-awarded-soderbergska-priset-i-medicin-2014
Professor Leif Groop, Lund University, has been awarded Söderbergska priset i medicin 2014 (the Söderberg award for medicine 2014) for his pioneering work in diabetes research both in relation to general and clinical research.1126Wed, 18 Dec 2013 00:00:00 +0100News | Lund university18 millions to Marju Orho-Melander for extraordinary researchhttps://ludc.prodwebb.lu.se/article/18-millions-to-marju-orho-melander-for-extraordinary-research
Marju Orho-Melander, professor in genetic epidemiology at Lund Univeristy, will receive a grant from the Swedish research Council for being an extraordinary younger scientist. 18 milliongs allocated in six years, will provide more efficiant strategies for prevention cardiometabolic diseases and cancer.
1125Fri, 13 Dec 2013 00:00:00 +0100News | Lund universityMajor prize for LU diabetes researcherhttps://ludc.prodwebb.lu.se/article/major-prize-for-lu-diabetes-researcher
With around 350 million patients worldwide, diabetes is one of the world’s major public health problems. This year’s Fernström Foundation Nordic Prize, with prize money of SEK 1 million, goes to the internationally renowned diabetes researcher Leif Groop from Lund University in Sweden.1124Thu, 19 Sep 2013 00:00:00 +0200News | Lund universityCould supplements during pregnancy reduce child diabetes risk?https://ludc.prodwebb.lu.se/article/could-supplements-during-pregnancy-reduce-child-diabetes-risk
Is it time for a new nutritional supplement during pregnancy to prevent type 1 diabetes in the unborn child? Two new scientific studies, one from Lund University in Sweden, and another from Finland, suggest so.1123Thu, 05 Sep 2013 00:00:00 +0200News | Lund universityEpigenetic changes to fat cells following exercisehttps://ludc.prodwebb.lu.se/article/epigenetic-changes-to-fat-cells-following-exercise
Exercise, even in small doses, changes the expression of our innate DNA. New research from Lund University in Sweden has described for the first time what happens on an epigenetic level in fat cells when we undertake physical activity.1122Thu, 04 Jul 2013 00:00:00 +0200News | Lund universityNew mouse model confirms how type 2 diabetes developshttps://ludc.prodwebb.lu.se/article/new-mouse-model-confirms-how-type-2-diabetes-develops
Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment. Long-term studies of the middle-aged mouse model will be better than previous studies at confirming how drugs for type 2 diabetes function in humans.1121Tue, 02 Jul 2013 00:00:00 +0200News | Lund universityProtein block stops vascular damage in diabeteshttps://ludc.prodwebb.lu.se/article/protein-block-stops-vascular-damage-in-diabetes
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.1120Tue, 04 Jun 2013 00:00:00 +0200News | Lund universityInflammation inhibitorial medicines will prevent type 2 https://ludc.prodwebb.lu.se/article/inflammation-inhibitorial-medicines-will-prevent-type-2
Using a simple blood sample, it is now possible to identify people at risk of developing type 2 diabetes in the future. In a new project, Anders Rosengren, researcher at Lund University Diabetes Centre and physician at Skåne University Hospital in Malmö, has identified a new risk protein for type 2 diabetes. 1119Thu, 23 May 2013 00:00:00 +0200News | Lund universityMethod which repairs damaged geneshttps://ludc.prodwebb.lu.se/article/method-which-repairs-damaged-genes
In recent years, researchers have discovered around 70 genetic risk variants for diabetes, but still TCF7L2, known as the diabetes gene, is the gene that carries with it the largest risk of developing type 2 diabetes. Using a new method called exon skipping, Ola Hansson at Lund University Diabetes Centre (LUDC) wants to learn more about TCF7L2 by studying new ways of delaying the onset of type 2 diabetes in animal trials.1118Wed, 22 May 2013 00:00:00 +0200News | Lund universityEarly partial answer to why obesity operations cause remission of diabeteshttps://ludc.prodwebb.lu.se/article/early-partial-answer-to-why-obesity-operations-cause-remission-of-diabetes
The majority of patients with type 2 diabetes who undergo a gastric bypass operation recover from the disease within a few days of the operation, long before their body weight falls. No one knows how this happens, but researchers at Lund University Diabetes Centre in Sweden have now come up with a partial answer.
In the long term, we aim to identify new treatment strategies that could imitate the operation’s anti-diabetic effect.1117Tue, 30 Apr 2013 00:00:00 +0200News | Lund universityNew clues in hunt for heredity in type 2 diabeteshttps://ludc.prodwebb.lu.se/article/new-clues-in-hunt-for-heredity-in-type-2-diabetes
Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research from Lund University in Sweden shows that we can modify the function of the genes through the epigenetic changes that take place in the course of life. Epigenetic changes are usually described as a link between heredity and environment and come about as a result of factors such as ageing, chemicals, medication, diet, exercise and drugs.1116Tue, 12 Mar 2013 00:00:00 +0100News | Lund universityNew grants from Hjelt foundationhttps://ludc.prodwebb.lu.se/article/new-grants-from-hjelt-foundation
Anders Rosengren and Ola Hansson from Lund University Diabetes Centre has been granted with 50.000 euro each from the Bo &amp; Kerstin Hjelt Foundation for type 2 diabetes research.1115Thu, 31 Jan 2013 00:00:00 +0100News | Lund universityCould normal water prevent diabetes, obesity and cardiovascular disease?https://ludc.prodwebb.lu.se/article/could-normal-water-prevent-diabetes-obesity-and-cardiovascular-disease
Researchers at Lund University, Sweden, are studying whether it is possible to prevent obesity, diabetes and cardiovascular disease by reducing levels of the hormone vasopressin in the blood.
- If you dilute the blood by drinking water, the body releases less of the hormone vasopressin, which can potentially lead to diabetes, says Sofia Enhörning, a doctor who has recently completed her PhD at Lund University.1114Thu, 20 Dec 2012 00:00:00 +0100News | Lund universityProtein reveals diabetes risk many years in advancehttps://ludc.prodwebb.lu.se/article/protein-reveals-diabetes-risk-many-years-in-advance
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be pTextut in place.
Researchers at Lund University have now identified a promising candidate for a test of this kind. The findings have been published in the journal Cell Metabolism.1113Wed, 07 Nov 2012 00:00:00 +0100News | Lund universityCould oral insulin prevent or delay diabetes?https://ludc.prodwebb.lu.se/article/could-oral-insulin-prevent-or-delay-diabetes
Could a capsule of insulin crystals a day stop the development of type 1 diabetes? There are indications that this could be the case. In the international TrialNet study, which follows relatives of individuals with type 1 diabetes, researchers are investigating whether oral insulin could prevent or delay the disease.1112Mon, 24 Sep 2012 00:00:00 +0200News | Lund universityBroader approach provides new insight into diabetes geneshttps://ludc.prodwebb.lu.se/article/broader-approach-provides-new-insight-into-diabetes-genes
Using a new method, diabetes researchers at Lund University, Sweden, have been able to reveal more of the genetic complexity behind type 2 diabetes. The new research findings have been achieved as a result of access to human insulin-producing cells from deceased donors and through not only studying one gene variant, but many genes and how thay influcence the level of the gene in pancreatic islets and their effect on insulin secretion and glucose control of the donor.1111Tue, 28 Aug 2012 00:00:00 +0200News | Lund universityThe 2012 Jahre Prize awarded to Professor Leif Groophttps://ludc.prodwebb.lu.se/article/the-2012-jahre-prize-awarded-to-professor-leif-groop
The Anders Jahre Senior Medical Prize for 2012 of one million Norwegian crowns is awarded to professor Leif Groop, coordinator of Lund University Diabetes Centre. He receives the prize for his ground-breaking research on diabetes, especially for his identification of hereditary factors that predispose to this disease group.1110Thu, 16 Aug 2012 00:00:00 +0200News | Lund universityScientific grade in world class - commendation and resumed confidencehttps://ludc.prodwebb.lu.se/article/scientific-grade-in-world-class-commendation-and-resumed-confidence
International experts has on behalf of the Swedish Research Council evaluated the first five years activity of Lund University Diabetes Centre (LUDC). The half time evaluation is underlying for the continous grant for the coming five years. All together the rating is &quot;Very well accomplished&quot;.1109Fri, 15 Jun 2012 00:00:00 +0200News | Lund universityAwarded for mapping the "hormone of darkness"https://ludc.prodwebb.lu.se/article/awarded-for-mapping-the-hormone-of-darkness
For the eight year in a row, Diabetes Research Day is arranged by the Diabetes Programme at Lund University. Apart from several scientific lectures, two awards are handed out. The award that is presented to a PhD student at Lund University Diabetes Centre (LUDC) this year goes to Cecilia Nagorny.
She receives this year´s student award in competition with a lot of other PhD students at LUDC. The reasons are described as her carefully prepared project plan and the scientific content ant the news worthiness of her research. 1108Thu, 08 Mar 2012 00:00:00 +0100News | Lund university2012 Edward James Olmos Award for Advocacy in Amputation Preventionhttps://ludc.prodwebb.lu.se/article/2012-edward-james-olmos-award-for-advocacy-in-amputation-prevention
DPCon2012 Conference Co-chairmen George Andros, MD, and David G. Armstrong, DPM, MD, PhD, are pleased to announce that the Edward James Olmos Award for Advocacy in Amputation Prevention Honoree for 2012 is Jan Apelqvist, MD, PhD.1107Wed, 29 Feb 2012 00:00:00 +0100News | Lund universityUncertain diagnosis for every fifth diabetes patienthttps://ludc.prodwebb.lu.se/article/uncertain-diagnosis-for-every-fifth-diabetes-patient
Despite of more advanced methods than in the routin care it will not be determined which kind of diabetes every fifth new diabetic patient is suffering from. In the ANDIS-project (All New Diabetics In Scania) the concepts will be sorted out. ANDIS also shows that one form of diabetes, LADA, which 15 years ago not even was described is twice as common today as type 1 diabetes.1106Mon, 05 Dec 2011 00:00:00 +0100News | Lund universityMolecular link between diabetes and cancer describedhttps://ludc.prodwebb.lu.se/article/molecular-link-between-diabetes-and-cancer-described
The fact that diabetes rases the risk of certain types of cancer is already well known, but the reasons have been unclear. Now researchers at Lund University in Sweden have mapped a molecular link that explains the connection between the two widespread diseases.1105Mon, 14 Nov 2011 00:00:00 +0100News | Lund universityHeart research recieves 15 millions Swedish crownshttps://ludc.prodwebb.lu.se/article/heart-research-recieves-15-millions-swedish-crowns
Professor Olle Melander at Lund University Diabetes Centre and Skåne University Hospital in Malmö recieves Heart- and Lung Foundation´s large grant of 15 millions swedish crowns.1104Wed, 22 Jun 2011 00:00:00 +0200News | Lund universityStill hope for GAD diabetes vaccinehttps://ludc.prodwebb.lu.se/article/still-hope-for-gad-diabetes-vaccine
Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is continuing as planned, and now with more money behind it.
&quot;I am still hopeful that the GAC vaccine will work&quot;, says Helena Elding Larsson.1103Tue, 21 Jun 2011 00:00:00 +0200News | Lund universityPrize for the best scientific article in Scandinaviahttps://ludc.prodwebb.lu.se/article/prize-for-the-best-scientific-article-in-scandinavia
Sofia Enhörning is the younger researcher in Scandinavia who wrote the best scientific article of the year within diabetes research. This means the Scandinavian Society for the Study of Diabetes (SSSD) which gives away the prize to her at the recent congress in Reykjavik.1102Mon, 13 Jun 2011 00:00:00 +0200News | Lund universityHow can metabolic surgery cure diabetes so fasthttps://ludc.prodwebb.lu.se/article/how-can-metabolic-surgery-cure-diabetes-so-fast
No one can explain this strange phenomenon. The majority of type 2 diabetics who undergo metabolic surgery recover from diabetes only a few days after the procedure, long before any weight loss has occurred. Now researchers at Lund University Diabetes Centre plan to find out what is happening by studying both patients and pigs before and after metabolic surgery.1101Wed, 13 Apr 2011 00:00:00 +0200News | Lund universityA large grant for exporing the epigenetics in diabeteshttps://ludc.prodwebb.lu.se/article/a-large-grant-for-exporing-the-epigenetics-in-diabetes
Charlotte Ling, researcher at Lund University Diabetes Centre, receives this year´s Novo Nordisk Foundation Excellence Project grant, five millions Danish crowns allocated during five years. Her project is about exploring whether epigenetic factors are underlying the development of Type 2 Diabetes.1100Fri, 25 Mar 2011 00:00:00 +0100News | Lund universityCollision between genes and life stylehttps://ludc.prodwebb.lu.se/article/collision-between-genes-and-life-style
Type 2 Diabetes is the fastest growing disease in the world of today. The cause is that we are not biologically adapted to our way of living.1099Thu, 27 Jan 2011 00:00:00 +0100News | Lund universityTwo world leading researchers receivs the ERC Advanced Granthttps://ludc.prodwebb.lu.se/article/two-world-leading-researchers-receivs-the-erc-advanced-grant
The professors Patrik Brundin and Leif Groop have from the European Research Council (ERC) been awarded the Advanced Grant for 2010.1098Mon, 24 Jan 2011 00:00:00 +0100News | Lund universityWhy are some diabetics free of complicationshttps://ludc.prodwebb.lu.se/article/why-are-some-diabetics-free-of-complications
Researchers are now asking the question the other way around. They want to know why some diabetic patients do not develop complications. What is protecting them? The PROLONG study may provide the answer.
- The majority of diabetics will over time develop severe or lethal complications, but 10-15 percent never do. They are the ones we are interested in the PROLONG study, explains Valeriya Lyssenko who along with Peter Nilsson, both from Lund University Diabetes Centre, lead the PROLONG study.1097Fri, 21 Jan 2011 00:00:00 +0100News | Lund universityA disturbance in the cellular power plant increases the risk of diabeteshttps://ludc.prodwebb.lu.se/article/a-disturbance-in-the-cellular-power-plant-increases-the-risk-of-diabetes
Research groups in close collaboration in Malmö have shed light on the pathway whereby a common genetic risk variant leads to impaired mitochondrial function of insulin cells. The variant in question impairs the capacity to secrete insulin and increases the risk of developing diabetes. The discovery is published in the highly ranked scientific journal Cell Metabolism.1096Mon, 13 Dec 2010 00:00:00 +0100News | Lund universityAre you related to someone with type 1 diabetes?https://ludc.prodwebb.lu.se/article/are-you-related-to-someone-with-type-1-diabetes
TrialNet studies are now starting in Sweden, with the initial trials in Skåne. TrialNet is an international network of researchers who are investigating possible ways to prevent, delay and reverse the development of type 1 diabetes.1095Mon, 15 Nov 2010 00:00:00 +0100News | Lund universityHeight study casts light on genetic mechanismshttps://ludc.prodwebb.lu.se/article/height-study-casts-light-on-genetic-mechanisms
An extensive global gene-mapping project has identified a large number of loci that dictate whether a person is tall or short. The aim of the project is to find out more about how many genes interact to form biologically interesting mechanisms behind diseases. &quot;Height on its own is perhaps not tremendously interesting but it serves as a good indicator when determining how genetic mechanisms work&quot;, says Martin Ridderstråle, Lund University Diabetes Centre, who is one of the researchers behind the study, the results of which were recently published in the highly respected journal Nature.1094Mon, 25 Oct 2010 00:00:00 +0200News | Lund universityLeif Groop, Diabetologist of the year 2010https://ludc.prodwebb.lu.se/article/leif-groop-diabetologist-of-the-year-2010
Leif Groop, professor in diabetes and endocrinology at Lund University Diabetes Centre and consultant at the Endocrinological Department at Skåne University Hospital Malmö, has been elected to the diabetologist of the year by the Swedish Society of Diabetology. 1093Fri, 22 Oct 2010 00:00:00 +0200News | Lund universityLund´s Fernström prize goes to research on genes https://ludc.prodwebb.lu.se/article/lunds-fernstrom-prize-goes-to-research-on-genes
Marju Orho-Melander, professor of genetic epidemiology in Malmö, has been awarded Lund University’s Fernström prize. Her research is about genetic variants that are associated with blood lipids and lipoproteins and can therefore increase the risk of cardiovascular disease.1092Thu, 09 Sep 2010 00:00:00 +0200News | Lund universityKick-off for a large venture in diabetes researchhttps://ludc.prodwebb.lu.se/article/kick-off-for-a-large-venture-in-diabetes-research
The goal is set high, that during the coming ten years develop new methods to prevent, cure and treat diabetes.
- Ambitious, but not unrealistic, says Leif Groop, coordinator for EXODIAB, the joint research project that Lund and Uppsala now will launch with a conference in Malmö September 9-10th.1091Mon, 06 Sep 2010 00:00:00 +0200News | Lund university